CVS Health Corp. (CVS) has increased its full year 2022 adjusted EPS guidance range to $8.40 to $8.60 from prior guidance range of $8.20 to $8.40. GAAP EPS is now expected to be in a range of $7.23 to $7.43, revised from $6.93 to $7.13. The company raised cash flow from operations guidance range to $12.5 billion to $13.5 billion from $12.0 billion to $13.0 billion.
from RTT - Earnings https://ift.tt/KnMdqjD
via IFTTT
No comments:
Post a Comment